Drug profile

The FDA adverse-event record for Aloe Vera + Glycerin + Lactic Acid + Salicylic Acid

13 adverse-event reports submitted to the FDA Center for Veterinary Medicine reference Aloe Vera + Glycerin + Lactic Acid + Salicylic Acid. See the species affected, top reactions, and outcomes below.

13
adverse-event reports
0.0%
death-coded share
Dog
most-reported species
5
Lack of efficacy - NOS - top reaction
Verify with FDA CVM →
Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
13
Total Reports
0
Deaths Reported
0.0%
Death Rate

Active Ingredients

Aloe Vera + Glycerin + Lactic Acid + Salicylic Acid

Administration Routes

Auricular (Otic)UnknownOther

Species Affected

Dog 12
Cat 1

Most Affected Breeds

Boxer (German Boxer) 2
Shepherd Dog - German 2
Retriever - Labrador 1
Domestic Shorthair 1
Terrier - Jack Russell 1
Chihuahua 1
Pug 1
Bulldog 1
Retriever - Golden 1
Bichon Frise 1

Most Reported Reactions

Lack of efficacy - NOS 5
Deafness 3
Ear discharge 1
Sneezing 1
Horner's syndrome 1
Polyphagia 1
Polydipsia 1
Cystitis 1
Pruritus 1
Haematuria 1
Other ear disorder NOS 1
Partial lack of efficacy 1

Outcome Breakdown

Outcome Unknown
7 (53.8%)
Ongoing
5 (38.5%)
Recovered with Sequela
1 (7.7%)

Aloe Vera + Glycerin + Lactic Acid + Salicylic Acid Adverse Event Insights

13 reports name Aloe Vera + Glycerin + Lactic Acid + Salicylic Acid; 0 recorded a death outcome (0.0% of reported events, not a population-level mortality rate). Active ingredient: Aloe Vera + Glycerin + Lactic Acid + Salicylic Acid. Administration routes: Auricular (Otic), Unknown, Other.

By species: Dog (12 reports), Cat (1 reports). By breed: Boxer (German Boxer) (2), Shepherd Dog - German (2), Retriever - Labrador (1).

Leading clinical signs: Lack of efficacy - NOS (5), Deafness (3), Ear discharge (1), Sneezing (1). Outcome, 13 coded reports: Outcome Unknown leads at 53.8%.

Read these counts as reporting volume, not risk: per our methodology, a widely-prescribed drug will rack up more raw FDA reports in a given year than a rarely-used one at an identical true rate, so we recommend comparing within similar-exposure products rather than across the full 2025 catalog.

Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025

Every figure on PlainBreed is rendered directly from FDA openFDA adverse event data, no number is typed in by an editor. This page draws directly on FDA openFDA data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.